Which atypical antipsychotic?
- 1 February 1998
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 172 (2) , 106-109
- https://doi.org/10.1192/bjp.172.2.106
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Cost Analysis of the Treatment of Schizophrenia in the UKPharmacoEconomics, 1998
- 532: Predictors of response to clozapine in a long-term double blind treatment studySchizophrenia Research, 1997
- Risperidone: How Good Is the Evidence for Efficacy?Schizophrenia Bulletin, 1997
- Risperidone in the treatment of schizophrenia: a meta-analysis of randomized controlled trialsJournal of Psychopharmacology, 1997
- Risperidone vs. Haloperidol in treatment resistant schizophreniaSchizophrenia Research, 1997
- L-4 Focusing on serotonin for the action of drugs effective in mood disorders: pre-synaptic versus postsynaptic mechanismsEuropean Neuropsychopharmacology, 1996
- Risperidone in the treatment of negative symptoms of schizophreniaInternational Clinical Psychopharmacology, 1995
- Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus HaloperidolThe British Journal of Psychiatry, 1995
- Psychomotor impairment and cognitive disturbances induced by neurolepticsActa Psychiatrica Scandinavica, 1994
- Assessment of Costs and Benefits of Drug Therapy for Treatment-Resistant Schizophrenia in the United KingdomThe British Journal of Psychiatry, 1993